A phase II study of regional 2-weekly 5-fluorouracil infusion with intravenous folinic acid in the treatment of colorectal liver metastases

British Journal of Cancer

Volumn 76, Issue 10, 1997, Pages 1390-1393

  Howell, J D ^a   McArdle, C S ^a   Kerr, D J ^b   Buckles, J ^b   Ledermann, J A ^c   Taylor, I ^c   Gallagher, H J ^a   Budden, J ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Chemotherapy; Colorectal cancer; Infusion intra arterial; Liver metastases

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID;

ABSCESS; ADULT; AGED; ANGINA PECTORIS; ARTERY CATHETER; ARTICLE; BLOOD TOXICITY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DRUG RESPONSE; FEMALE; FOLLOW UP; GASTRITIS; HEMATOMA; HEPATIC ARTERY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LUNG METASTASIS; MALE; METASTASIS; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REGIONAL PERFUSION; VOMITING;

EID: 0030667317     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.566     Document Type: Article

References (17)

1. Advanced Colorectal Cancer Meta-analysis Project (1992) Modulation of Fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903
2. Allen-Mersh T, Earlam S, Fordy C, Abrams K and Houghton J (1994) Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344: 1255-1260
3. Anderson JH, Goldberg JA, Lieberman DP, Stewart I, Cooke TG and McArdle CS (1992) The use of a saphenous vein graft to circumvent anatomical variations encountered at surgical insertion of a hepatic artery catheter. Eur J Surg Oncol 18: 484-486
4. Blijham G, Wagener T, Wils J, De Greve J, Buset M, Bleiberg H, Lacave A, Dalmark M, Selleslag J, Collette L and Sahmoud T (1996) Modulation of high dose infusional fluorouracil by low dose methotrexate in patients with advanced or metastatic colorectal cancer. J Clin Oncol 14: 2266-2273
5. Breedis C and Young C (1954) The blood supply of neoplasm in the liver. Am J Pathol 30: 969-974
6. Chang AE, Schneider PD, Sugarhaker PH, Simpson C, Culne M and Steinberg SM (1987) A prospective randomised trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206: 685-693
7. De Gramont A, Krulik M, Cady J, Lagadec B, Maisani J and Loiseau J (1988) High dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer. Eur J Clin Oncol 24: 1499-1503
8. Gamelin E, Danquechin-Dorval E, Dumesnil Y, Maillart, P. Goudier M and Burtin P (1995) Relationship between 5-fluorouracil dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU. Cancer 77: 441-451
9. Hohn DC, Stagg RJ, Friedman MA, Hannigan JR, Raynor A, Ignoffo RJ, Acord P and Lewis BJ (1989) A randomised trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 7: 1646-1654
10. Howell JD, Gallagher H, Kane E, Maguire R and McArdle CS (1997) Infusion pumps for systemic and intra-arterial chemotherapy of colorectal liver metastases. Ann R Coll Surg Engl 79: 257-258
11. Kemeny MM, Goldberg D, Beatty JD, Blayney D, Browning S, Doroshaw J, Ganteaume L, Hill RL, Kokal WA, Riihimaki DU and Terz JJ (1986) Results of a prospective randomised trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer. Cancer 57: 492-498
12. Kemeny N, Daly J, Reichman B, Geller N, Botet J and Oderman P (1987) Intrahepatic or systemic infusion of floxuridine in liver metastases from colorectal carcinoma. A randomised trial. Ann Intern Med 107: 459-465
13. Kerr D, Ledermann JA, McArdle C, Buckels J, Neoptolemos J, Seymor M, Doughty J, Budden J and Taylor I (1995) Phase I clinical and pharmacokinetic study of folinic acid and infusional hepatic arterial 5-Fluorouracil. J Clin Oncol 13: 2968-2972
14. Martin JK, O'Connell MJ, Wieand HS, Fitzgibbons RJ, Maillard JA, Rubin J. Nagorney DM, Tschetter LK and Krook JE (1990) Intra-arterial floxundine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomised trial. Arch Surg 125: 1022-1027
15. Medical Research Council (1994) A Randomised Trial of Intravenous versus Intrahepatic Arterial 5-FU and Leucovorin for Colorectal Liver Metastases. MRC: Cambridge
16. Meta-analysis Group in Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88: 252-258
17. Rougier P, Laplanche A, Huguier M, Hay J, Ollivier J, Escat J, Salmon R and Julien M (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomised trial. J Clin Oncol 10: 1112-1118